Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan–implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2
Tao Liu, MD1*; Sanyun Wu, MD, PhD2*; Huangheng Tao, PhD3*; Guang Zeng, MD1; Fuling Zhou, MD2 †; Fangjian Guo, MD, PhD4,5†; Xinghuan Wang, MD1†
https://www.medrxiv.org/content/10.1101/2020.06.13.20130252v1.full.pdf
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Antibody dynamics to SARS-CoV-2 in Asymptomatic and Mild COVID-19 patients
SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months
Comparative performance of five commercially available serologic assays to detect antibodies to SARS-coV-2 and identify individuals with high neutralizing titers.
Related
Antibody dynamics to SARS-CoV-2 in Asymptomatic and Mild COVID-19 patients
SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months
Comparative performance of five commercially available serologic assays to detect antibodies to SARS-coV-2 and identify individuals with high neutralizing titers.